We investigated the frequency and distribution of glomerular thrombosis (GT) in 108 renal biopsies of lupus patients and correlated this finding with the presence of anticardiolipin antibodies (ACLA). GT was present mainly in the diffuse proliferative form. The activity index was higher in those patients with GT (12.9 ± 4.7 vs 5.4 ± 4.1, P < 0.01). The more severe histologic features, necrosis and extracapillary proliferation were also related with GT. In 18 cases with repeated biopsy the best predictors for the subsequent development of glomerular sclerosis were fibrinoid necrosis (P < 0.01), glomerular infiltration (P < 0.01) and an activity index of 10 or more (P < 0.05). GT also showed to be an important prognostic factor for sclerosis, although no statistically significant. ACLA were investigated in 36 patients at the time of renal biopsy. There were nine positive cases and in three of them this finding was related to GT. We can conclude that GT is a relevant feature showing active lupus nephritis and that it is not related to the presence of ACLA.
Austin HA, Muenz LR, Joyce KM et al. Diffuse proliferative lupus nephritis: identification of specific pathologic features affecting renal outcome. Kidney Int1984; 25: 689-95.
3.
Baldwin DSClinical usefulness of the morphological classification of lupus nephritis . Am J Kidney Dis1982; 2(Suppl. 1): 142-49.
4.
Esdaile JM, Levinton C., Federgreen W.The clinical and renal biopsy predictors of long-term outcome in lupus nephritis: a study of 87 patients and review of the literature. Q J Med1989; 72: 779-802.
5.
Magil AB, Ballon HS, Chan V. et al. Diffuse proliferative lupus glomerulonephritis. Determination of prognostic significance of clinical, laboratory and pathologic factors. Medicine1984; 63: 210-20.
6.
Whiting-O'Keefe Q., Henke JE, Shearn MA et al. The information content from renal biopsy in systemic lupus erythematosus. Ann Intern Med1982; 96: 718-23.
7.
Nossent HC, Hentzel-Logmans SC, Vroom TM et al. Contribution of renal biopsy data in predicting outcome in lupus nephritis. Analysis of 116 patients. Arthritis Rheum1990; 33: 970-7.
8.
Ballow JE, Austin HA, Tsokos GC et al. Lupus nephritis. Ann Intern Med1987; 106: 79-94.
9.
Oliveira DB, Peters DKAutoimmunity and the kidney. Kidney Int1989 ; 35: 923-8.
10.
Jancock W., Atkins R.Activation of coagulation pathways and fibrin deposition in human glomerulonephritis . Semin Nephrol1985; 5: 69-77.
11.
Kant KS, Pollak VE, Weiss MA et al. Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine1981; 60: 71-86.
Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1982; 25: 1271-7.
14.
Morel-Maroger L., Mery JP, Droz D. et al. The course of lupus nephritis: contribution of serial renal biopsies. Adv Nephrol1976 ; 6: 79-118.
15.
Lee HS, Mujais SK, Kasinath BS et al. Course of renal pathology in patients with systemic lupus erythematosus . Am J Med1984; 77: 612-20.
16.
McLaughlin J., Gladman ED, Urowitz MD et al. Kidney biopsy in systemic lupus erythematosus. II. Survival analysis according to biopsy results. Arthritis Rheum1991; 34: 1268-73.
17.
Parbtani A. , Frampton G., Yedwall V. et al. Platelet and plasma serotonin in glomerulonephritis. III. The nephritis of systemic lupus erythematosus. Clin Nephrol1980; 14: 164-72.
18.
Kasai N., Parbtani A., Cameron JSPlatelet aggregating immune complexes and intraplatelet serotonin in idiopathic glomerulonephritis and systemic lupus erythematosus. Clin Exp Immunol1981; 43: 64-71.
19.
Daffus P., Parbtani A., Frampton C. et al. Intraglomerular localization of platelet related antigen, platelet factor 4 and thramboglobulin in glomerulonephritis. Clin Nephrol1982; 17: 288-97.
20.
Glas-Greenwald T., Kant KS, Allen CA et al. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus . J Lab Clin Med1984; 104: 962-76.
21.
Schreinger GF, Cotran RS, Unanue ER et al. Macrophages and cellular immunity in experimental glomerulonephritis. Springer Semin Immunopathol1982; 5: 251-68.
22.
Camussi G., Tetta C., Mazzucco G. et al. Platelet cationic proteins are present in glomeruli of lupus nephritis patients. Kidney Int1986; 30: 555-65.
23.
Suzuki M., Hatakeyama A., Kameoka J. et al. Anti-DNA idiotypes deposited in renal glomeruli of patients with lupus nephritis. Am J Kidney Dis1991 ; 27: 232-9.
24.
Couser MBMechanisms of glomerular injury in immune complex disease. Kidney Int1985; 28: 569-83.
25.
Kincaid-Smith P.Anticoagulants are of value in the treatment of renal disease. Am J Kidney Dis1984; 3: 299-307.
26.
Donadio JB, Anderson CF, Mitchell JC et al. Membranoproliferative glomerulonephritis. A prospective trial of platelet-inhibitor therapy. New Eng J Med1984; 310: 1421-7.
27.
Hariharan S. , Pollak VE, Kant KSDiffuse proliferative lupus nephritis: long-term observations in patients treated with ancrod. Clin Nephrol1990; 34: 61-9.
28.
Glueck HI, Kant KS, Weiss MA et al. Thrombosis in systemic lupus erythematosus: relation to the presence of circulating anticoagulants. Arch Intern Med1985; 145: 1389-95.
29.
Harris EN, Gharavi AE, Boey ML et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet1983; 2: 1211-14.
30.
Frampton G. , Kicks J., Stewart CJ et al. Significance of antiphospholipid antibodies in patients with lupus nephritis. Kidney Int1991; 39:1225-31.
31.
Weidmann CE , Wallace DJ, Peter JB et al. Studies of IgG, IgM and IgA anti phospholipid antibodies isotypes in systemic lupus erythematosus . J Rheumatol1988; 15: 74-9.
32.
Perez-Vazquez ME, Cabiedes BS, Cabral A. et al. Decrease in serum antiphospholipid antibody levels upon development of nephrotic syndrome in patients with systemic lupus erythematosus: relationship to urinary loss of IgG and other factors . Am J Med1992; 92: 357-62.
